Generics - Biotechnology, Financial

Filter

Current filters:

BiotechnologyFinancial

Popular Filters

Pharma associations strongly support Senate bill on FDA User Fees sequestration exemptions

05-08-2013

In the USA last week, Mark Pryor (Democrat, Arkansas), chairman of the Senate Appropriations Subcommittee…

BiotechnologyFinancialGenericsLegalNorth AmericaPharmaceuticalPolitics

Increased focus on generics and biosimilars only way to make European health care sustainable, says EGA

13-06-2013

Addressing delegates at the 19th European Generic medicines Association (EGA) Annual Conference in Athens,…

BiotechnologyEuropeFinancialGenericsHealthcareRegulation

EMA 2013 work program and budget endorsed by management board

18-12-2012

The European Medicines Agency's Management Board revealed yesterday that, at its meeting on December…

BiotechnologyEuropeFinancialGenericsPharmaceuticalRegulation

Medicines for normal aging conditions overtakes costs of treating most chronic diseases; Express Scripts

30-10-2012

In the USA, prescription-drug treatment regimens for conditions that are a normal part of aging are now…

BiotechnologyFinancialGenericsHealthcareNorth AmericaPharmaceutical

News briefs: Genmab/GSK, Gilead and Mylan

24-05-2012

Denmark's Genmab (OMX: GEN) yesterday received a milestone payment of 20 million Danish kroner ($3.4…

Anti-viralsBiotechnologycobicistatFinancialGenericsGenmabGilead SciencesGlaxoSmithKlineMylan LaboratoriesOncologyRegulationViramune

COMPANY SPOTLIGHT

Menarini

Back to top